FIND2CURE
FIND2CURE
We offer a comprehensive precision oncology solution that includes the seamless integration of molecular profiling and biomarker-guided trial portfolios, allowing patients to benefit from new and improved treatments.
More Treatment Insights are available. Per patient participating in the F2C Trial receives comprehensive genomic and gene expression profiling. More Patients, More Results Tumor molecular profiling tests that use 10 times less tissue than other leading tests and offer treatment selection outcomes to 50%+ more patients.
More Treatment Alternatives A list of biomarker-guided trials that are currently available in your area.
We use clinical and molecular data sets from the F2C Trial to generate new perspectives that drive research and better clinical trials to provide patients with a very right and accurate treatment plans.
to ensure that each patient receives the best possible cancer care.
Our approach is built on the F2C Trial, a leading clinical genomics study that provides a standardized, enterprise-wide molecular profiling protocol for patients with advanced cancer treatments, as well as a portfolio of biomarker-guided clinical trials. The F2C Trial records treatment decisions and results, allowing for the development of new molecular signals for treatments and the identification of novel biomarkers for precise drug matching the future of GENE-Drug Match research.
Comprehensive genomic profiling and gene expression profiling are performed on a regular basis to provide more complete molecular data to help direct treatment decisions. F2C NGS, our lead assay, is a rigorous genomic profiling test that delivers industry-leading results on small tumor tissue samples.
Our approach was created with the aim of expanding care options by providing local access to biomarker-guided trials. Patients with different biomarker profiles tested on our molecular profiling assays are enrolled in a series of precision trials. Patients will participate in trials at the primary cancer care centers of their partner's health system, giving them more care choices near to home.
We use clinical and molecular data from the F2C Trial to generate new perspectives that drive research and better clinical care. Cohort trials, biomarker identification, and investigator-initiated research design and execution are all supported by our clinical-molecular database. We learn from real-world data with our collaborators and quickly convert findings into prospective studies to patient’s treatment plans.
Please get in touch with our team.
HealthPlan@find2cure.com
Patient's health status & outcome
Insurance & Aided Programs
Evolving to Good Health
FIND2CURE